HEALTHALLAFRICA
Congo-Kinshasa: U.S. Releases Experimental Ebola Drug for DR Congo Outbreak Trials
The U.S. has released an experimental Ebola drug for clinical trials in the Democratic Republic of Congo as the outbreak surpasses 1,000 cases and 250 deaths, according to the World Health Organization and U.S. officials. The treatment is being shipped to the region to address the ongoing crisis.
Mentioned
Related Signal
Adjacent reporting
- Exclusive: Race begins to trial Ebola drugs amid current outbreak
- Brazil isolates two suspected Ebola cases as Congo outbreak exceeds 1,000 infections
- A new Ebola outbreak is confirmed in a remote Congo province, with 65 deaths recorded
- US doctor who contracted Ebola in the DRC flown to Germany for treatment
- Scientists Race to Test Treatments as Ebola Outbreak Widens